首页 > 最新文献

Asian Journal of Transfusion Science最新文献

英文 中文
Determinants of mortality after massive transfusion - A prospective study. 大量输血后死亡率的决定因素——一项前瞻性研究。
IF 0.6 Q4 HEMATOLOGY Pub Date : 2024-07-01 Epub Date: 2023-11-07 DOI: 10.4103/ajts.AJTS_116_18
Divya Venugopal, Susheela Jacob Innah, Aboobacker Mohamed Rafi, Ramesh Bhaskaran

Introduction: Massive hemorrhage calls for massive transfusions (MTs) to maintain adequate hemostasis. Massive transfusion protocols (MTPs) are the appropriate treatment strategy for such patients replacing conventional use of crystalloids. These help in standardizing and optimizing the delivery of blood components in a well-balanced ratio.

Aim and objectives: The aim of the study is to propose an ideal ratio of blood components for MTP after assessing relationship between ratios of blood components transfused and mortality.

Methodology: MT was defined as receiving >4 packed red blood cell (PRBC) units within 1 h with the anticipation of continued need for blood products. All MT patients above 13 years of age regardless of cause of bleed were included in the study from December 2015 to October 2017 accounting for a total of 61 patients. Subgroup categorization of study population was done, and physician-driven ratios of the blood components were calculated for each case. The ratios were grouped as high (>1), equal (=1), and low (<1) ratios of fresh frozen plasma (FFP):PRBC and platelet: PRBC, and the relationship of these ratios to the clinical outcome in terms of mortality was examined.

Results and discussion: Sixty-one patients underwent MT of which the overall hospital mortality rate was 8.1% with 100% mortality among patients with penetrating trauma followed by 25% with gastrointestinal bleed. Emergency admission was an independent risk factor for mortality. Hypotension before the initiation of MT was detrimental for survival. Efficient communication existed between the treating physicians and transfusion. Majority of survivors received equal ratios of FFP: PRBC and platelet: PRBC, and all nonsurvivors received low ratios of FFP: PRBC. Analysis was statistically indicating better survival with 1:1:1 ratio of PRBC: FFP: platelet.

Conclusion: The need of the hour is to establish an institutional MTP and ensure compliance with the same. A prospective randomized controlled trial needs to be done to overcome the limitations and confounders of the present study and establish a universal protocol.

简介:大出血需要大量输血(MTs)来维持充分的止血。大量输血方案(MTPs)是替代传统晶体药物使用的合适治疗策略。这有助于以均衡的比例标准化和优化血液成分的输送。目的和目的:本研究的目的是在评估输血血液成分比例与死亡率之间的关系后,提出MTP的理想血液成分比例。方法:MT被定义为在1小时内接受bb40个包装红细胞(PRBC)单位,预计持续需要血液制品。2015年12月至2017年10月,所有13岁以上的MT患者,不论出血原因,共61例纳入研究。对研究人群进行亚组分类,并计算每个病例血液成分的医生驱动比率。结果和讨论:61例患者接受了MT治疗,其中医院总死亡率为8.1%,其中穿透性创伤患者死亡率为100%,其次是25%的胃肠道出血患者。急诊入院是死亡的独立危险因素。MT开始前的低血压对生存不利。治疗医生和输血之间存在有效的沟通。大多数幸存者接受相同比例的FFP: PRBC和血小板:PRBC,所有非幸存者接受低比例的FFP: PRBC。统计分析表明,PRBC: FFP:血小板比例为1:1:1时生存率更高。结论:当务之急是建立一个制度性的MTP并确保其执行。需要进行前瞻性随机对照试验,以克服本研究的局限性和混杂因素,并建立一个通用的方案。
{"title":"Determinants of mortality after massive transfusion - A prospective study.","authors":"Divya Venugopal, Susheela Jacob Innah, Aboobacker Mohamed Rafi, Ramesh Bhaskaran","doi":"10.4103/ajts.AJTS_116_18","DOIUrl":"https://doi.org/10.4103/ajts.AJTS_116_18","url":null,"abstract":"<p><strong>Introduction: </strong>Massive hemorrhage calls for massive transfusions (MTs) to maintain adequate hemostasis. Massive transfusion protocols (MTPs) are the appropriate treatment strategy for such patients replacing conventional use of crystalloids. These help in standardizing and optimizing the delivery of blood components in a well-balanced ratio.</p><p><strong>Aim and objectives: </strong>The aim of the study is to propose an ideal ratio of blood components for MTP after assessing relationship between ratios of blood components transfused and mortality.</p><p><strong>Methodology: </strong>MT was defined as receiving >4 packed red blood cell (PRBC) units within 1 h with the anticipation of continued need for blood products. All MT patients above 13 years of age regardless of cause of bleed were included in the study from December 2015 to October 2017 accounting for a total of 61 patients. Subgroup categorization of study population was done, and physician-driven ratios of the blood components were calculated for each case. The ratios were grouped as high (>1), equal (=1), and low (<1) ratios of fresh frozen plasma (FFP):PRBC and platelet: PRBC, and the relationship of these ratios to the clinical outcome in terms of mortality was examined.</p><p><strong>Results and discussion: </strong>Sixty-one patients underwent MT of which the overall hospital mortality rate was 8.1% with 100% mortality among patients with penetrating trauma followed by 25% with gastrointestinal bleed. Emergency admission was an independent risk factor for mortality. Hypotension before the initiation of MT was detrimental for survival. Efficient communication existed between the treating physicians and transfusion. Majority of survivors received equal ratios of FFP: PRBC and platelet: PRBC, and all nonsurvivors received low ratios of FFP: PRBC. Analysis was statistically indicating better survival with 1:1:1 ratio of PRBC: FFP: platelet.</p><p><strong>Conclusion: </strong>The need of the hour is to establish an institutional MTP and ensure compliance with the same. A prospective randomized controlled trial needs to be done to overcome the limitations and confounders of the present study and establish a universal protocol.</p>","PeriodicalId":42296,"journal":{"name":"Asian Journal of Transfusion Science","volume":"18 2","pages":"182-190"},"PeriodicalIF":0.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11734799/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Red cell alloimmunization in chronic kidney disease. 慢性肾脏疾病的红细胞异体免疫。
IF 0.6 Q4 HEMATOLOGY Pub Date : 2024-07-01 Epub Date: 2022-12-12 DOI: 10.4103/ajts.ajts_121_22
Suvro Sankha Datta
{"title":"Red cell alloimmunization in chronic kidney disease.","authors":"Suvro Sankha Datta","doi":"10.4103/ajts.ajts_121_22","DOIUrl":"https://doi.org/10.4103/ajts.ajts_121_22","url":null,"abstract":"","PeriodicalId":42296,"journal":{"name":"Asian Journal of Transfusion Science","volume":"18 2","pages":"371-372"},"PeriodicalIF":0.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11734778/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of therapeutic plasma exchange in neuromyelitis optica: A retrospective study from South India. 血浆置换治疗视神经脊髓炎的安全性和有效性:一项来自南印度的回顾性研究。
IF 0.6 Q4 HEMATOLOGY Pub Date : 2024-07-01 Epub Date: 2022-09-28 DOI: 10.4103/ajts.ajts_18_22
Dibyajyoti Sahoo, Pragya Silwal, Abhishekh Basavarajegowda

Introduction: Neuromyelitis optica (NMO) is an idiopathic demyelinating disorder characterized mainly by optic neuritis and myelitis, causing gradual loss of vision and deterioration of neurological function. The underlying pathogenesis mainly involves antibodies against aquaporin 4. The effectiveness of therapeutic plasma exchange (TPE) has been shown by many studies across the globe but are only a few from India. We studied ten cases of NMO retrospectively to find out the safety and efficacy of plasma exchange and to know the outcome of those patients who underwent the procedure.

Materials and methods: We retrospectively analyzed ten cases of NMO who underwent TPE from January 2017 to July 2021. Out of 153 patients on whom plasma exchange procedures were done during this period, ten cases of NMO were diagnosed and managed with TPE.

Results: In our study, we found that 6 of our patients (60%) had a marked improvement noticed clinically with an increase in baseline power of limbs from 0-2/5 to 3-5/5. However, two patients expired after despite TPE. The other two did not show any improvement. Four of our patients started showing clinical improvement after the 2nd-3rd cycles of treatment. TPE was initiated early (within 5 days). There were no notable events in most of the procedures except in one procedure where the patient developed hypotension, her saturation started to drop, and the procedure had to be aborted.

Conclusion: Our study supports the effectiveness of timely initiation of plasma exchange to improve the overall mortality rate of the patients.

简介:视神经脊髓炎(Neuromyelitis optica, NMO)是一种以视神经炎和脊髓炎为主要特征的特发性脱髓鞘疾病,可导致视力逐渐丧失和神经功能恶化。潜在的发病机制主要涉及抗水通道蛋白4的抗体。治疗性血浆交换(TPE)的有效性已被全球许多研究证明,但只有少数来自印度。我们对10例NMO患者进行回顾性研究,以了解血浆置换的安全性和有效性,并了解患者的预后。材料和方法:我们回顾性分析了2017年1月至2021年7月期间接受TPE治疗的10例NMO患者。在此期间进行血浆置换手术的153例患者中,有10例NMO被诊断并使用TPE进行治疗。结果:在我们的研究中,我们发现6例患者(60%)在临床上有明显的改善,四肢的基线力量从0-2/5增加到3-5/5。然而,有2例患者在TPE后死亡。另外两个则没有任何改善。我们的4名患者在第2 -3个治疗周期后开始出现临床改善。TPE开始较早(5天内)。在大多数手术中没有明显的事件发生,除了一个病人出现低血压,她的饱和度开始下降,手术不得不中止。结论:本研究支持及时开始血浆置换对提高患者总体死亡率的有效性。
{"title":"Safety and efficacy of therapeutic plasma exchange in neuromyelitis optica: A retrospective study from South India.","authors":"Dibyajyoti Sahoo, Pragya Silwal, Abhishekh Basavarajegowda","doi":"10.4103/ajts.ajts_18_22","DOIUrl":"10.4103/ajts.ajts_18_22","url":null,"abstract":"<p><strong>Introduction: </strong>Neuromyelitis optica (NMO) is an idiopathic demyelinating disorder characterized mainly by optic neuritis and myelitis, causing gradual loss of vision and deterioration of neurological function. The underlying pathogenesis mainly involves antibodies against aquaporin 4. The effectiveness of therapeutic plasma exchange (TPE) has been shown by many studies across the globe but are only a few from India. We studied ten cases of NMO retrospectively to find out the safety and efficacy of plasma exchange and to know the outcome of those patients who underwent the procedure.</p><p><strong>Materials and methods: </strong>We retrospectively analyzed ten cases of NMO who underwent TPE from January 2017 to July 2021. Out of 153 patients on whom plasma exchange procedures were done during this period, ten cases of NMO were diagnosed and managed with TPE.</p><p><strong>Results: </strong>In our study, we found that 6 of our patients (60%) had a marked improvement noticed clinically with an increase in baseline power of limbs from 0-2/5 to 3-5/5. However, two patients expired after despite TPE. The other two did not show any improvement. Four of our patients started showing clinical improvement after the 2<sup>nd</sup>-3<sup>rd</sup> cycles of treatment. TPE was initiated early (within 5 days). There were no notable events in most of the procedures except in one procedure where the patient developed hypotension, her saturation started to drop, and the procedure had to be aborted.</p><p><strong>Conclusion: </strong>Our study supports the effectiveness of timely initiation of plasma exchange to improve the overall mortality rate of the patients.</p>","PeriodicalId":42296,"journal":{"name":"Asian Journal of Transfusion Science","volume":"109 1","pages":"248-251"},"PeriodicalIF":0.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11734803/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74752289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transfusion medicine hackathon: Nurturing the innovative ideas to revolutionize voluntary blood donation. 输血医学黑客马拉松:培育创新理念,变革无偿献血。
IF 0.6 Q4 HEMATOLOGY Pub Date : 2024-07-01 Epub Date: 2024-08-22 DOI: 10.4103/ajts.ajts_26_24
Shamee Shastry, Gajendra Nath Gupta, Sadhana Mangwana, Nabajyoti Choudhury, Arun Shanbhag, Suchet Sachdev

Background and objective: Blood transfusion is an essential component of health care. However, several issues can hamper the promotion and sustainability of voluntary blood donation programs. This article is about a hackathon in the field of transfusion medicine that was designed to stimulate original ideas to promote voluntary blood donation.

Materials and methods: The transfusion medicine hackathon was conducted as a joint project of an educational institute, the Asian Association of Transfusion Medicine, and the Innovation Center. It was conducted in eight main phases, which included planning and preparation, choosing the problem statement, participant recruitment and registration, launch, and mentoring as the first steps. Participants presented their ideas in the ideation phase, and the top five teams were selected for the prototyping phase. Selection was based on innovation/originality (10 points), feasibility (10 points), and social impact (5 points). In the prototype phase, two teams were selected as winners and were awarded by the organizers.

Results: A total of 36 multidisciplinary teams representing various parts of India pitched innovative ideas. The majority have proposed new strategies for the retention of blood donors to maintain the donor pool and teams came up with novel ideas aimed at enhancing the overall blood donation experience. One of the winning teams completed the project and launched the product.

Conclusion: Health-care hackathons promote interdisciplinary education and innovation. This is a first-of-its-kind effort from the field of transfusion medicine to explore a hackathon platform to promote voluntary blood donation.

背景和目的:输血是卫生保健的重要组成部分。然而,有几个问题会阻碍自愿献血计划的推广和可持续性。这篇文章是关于输血医学领域的黑客马拉松,旨在激发原创思想,促进自愿献血。材料和方法:输血医学黑客马拉松是一家教育机构、亚洲输血医学协会和创新中心的联合项目。它分八个主要阶段进行,包括计划和准备,选择问题陈述,参与者招募和注册,启动和指导作为第一步。参与者在构思阶段展示他们的想法,前五名团队被选中进入原型阶段。选择的依据是创新/原创性(10分)、可行性(10分)和社会影响(5分)。在原型设计阶段,有两支队伍被评选为优胜者,并由主办方给予奖励。结果:代表印度不同地区的36个多学科团队提出了创新想法。大多数人提出了保留献血者的新策略,以维持献血者池,团队提出了旨在提高整体献血体验的新想法。其中一个获胜团队完成了项目并推出了产品。结论:卫生保健黑客马拉松促进了跨学科教育和创新。这是输血医学领域首次探索一个促进自愿献血的黑客马拉松平台。
{"title":"Transfusion medicine hackathon: Nurturing the innovative ideas to revolutionize voluntary blood donation.","authors":"Shamee Shastry, Gajendra Nath Gupta, Sadhana Mangwana, Nabajyoti Choudhury, Arun Shanbhag, Suchet Sachdev","doi":"10.4103/ajts.ajts_26_24","DOIUrl":"10.4103/ajts.ajts_26_24","url":null,"abstract":"<p><strong>Background and objective: </strong>Blood transfusion is an essential component of health care. However, several issues can hamper the promotion and sustainability of voluntary blood donation programs. This article is about a hackathon in the field of transfusion medicine that was designed to stimulate original ideas to promote voluntary blood donation.</p><p><strong>Materials and methods: </strong>The transfusion medicine hackathon was conducted as a joint project of an educational institute, the Asian Association of Transfusion Medicine, and the Innovation Center. It was conducted in eight main phases, which included planning and preparation, choosing the problem statement, participant recruitment and registration, launch, and mentoring as the first steps. Participants presented their ideas in the ideation phase, and the top five teams were selected for the prototyping phase. Selection was based on innovation/originality (10 points), feasibility (10 points), and social impact (5 points). In the prototype phase, two teams were selected as winners and were awarded by the organizers.</p><p><strong>Results: </strong>A total of 36 multidisciplinary teams representing various parts of India pitched innovative ideas. The majority have proposed new strategies for the retention of blood donors to maintain the donor pool and teams came up with novel ideas aimed at enhancing the overall blood donation experience. One of the winning teams completed the project and launched the product.</p><p><strong>Conclusion: </strong>Health-care hackathons promote interdisciplinary education and innovation. This is a first-of-its-kind effort from the field of transfusion medicine to explore a hackathon platform to promote voluntary blood donation.</p>","PeriodicalId":42296,"journal":{"name":"Asian Journal of Transfusion Science","volume":"18 2","pages":"355-358"},"PeriodicalIF":0.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11734809/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is the curriculum of transfusion medicine in MBBS aligned with practical needs: A point of view of fresh graduates. MBBS的输血医学课程是否符合实际需要:应届毕业生的观点。
IF 0.6 Q4 HEMATOLOGY Pub Date : 2024-07-01 Epub Date: 2022-05-26 DOI: 10.4103/ajts.ajts_120_21
Umera Saleem, Muhammad Asif Naveed, Muhammad Samiullah, Urwah Tanveer, Shahroz Alam, Ahmed Faraz Zafar, Sohail Safdar

Objective: The objective of the study is to assess the satisfaction level of doctors regarding their competence in the blood transfusion process and their reflection on training at the undergraduate level.

Background: Transfusion errors due to suboptimal knowledge and lack of training can lead to grave outcomes. Therefore, to optimize patient care, a thorough understanding of transfusion medicine basics is highly imperative for all medical graduates.

Methodology: This survey was conducted online through Google forms with a questionnaire consisting of 15 questions. 8 medical colleges (4 government and 4 private) were selected by random cluster sampling technique. Data were analyzed with SPSS version 23.

Results: Of 502 participants, 53.8% were females and 69.9% were graduates of public medical colleges. About 84.6% did not receive any formal training on transfusion during graduation. Almost 82% felt that the current curriculum is not designed to meet their practical needs of blood transfusion and 52% agreed that knowledge of transfusion medicine is required for undergraduates. The survey also revealed that 70.5% of participants believed that whole blood is required for most patients and 49.8% did not feel confident to manage transfusion-related complications by themselves.

Conclusion: Our survey showed that our undergraduate curriculum is not aligned with the practical transfusion needs of a young doctor. As transfusions are being carried out by these young doctors, this needs to be addressed by revising the current curriculum and incorporating teaching and hands-on training to our medical graduates.

目的:本研究的目的是评估医生对其输血过程能力的满意度及其对本科阶段培训的反思。背景:由于知识不足和缺乏培训而导致的输血错误可能导致严重的后果。因此,为了优化患者护理,全面了解输血医学基础知识对所有医学毕业生来说都是非常必要的。调查方法:本调查采用谷歌在线表格进行,共15个问题。采用随机整群抽样方法,选取8所医学院校(4所公立,4所民办)。数据采用SPSS version 23进行分析。结果:502名参与者中,女性占53.8%,公立医学院毕业生占69.9%。约84.6%的人在毕业时没有接受过任何正规的输血培训。近82%的人认为目前的课程设计不能满足他们对输血的实际需求,52%的人认为输血医学知识是本科生必须具备的。调查还显示,70.5%的参与者认为大多数患者需要全血,49.8%的参与者对自己处理输血相关并发症没有信心。结论:我们的调查显示,我们的本科课程与年轻医生的实际输血需求不一致。由于输血是由这些年轻的医生进行的,这需要通过修改目前的课程来解决,并将教学和实践培训纳入我们的医学毕业生。
{"title":"Is the curriculum of transfusion medicine in MBBS aligned with practical needs: A point of view of fresh graduates.","authors":"Umera Saleem, Muhammad Asif Naveed, Muhammad Samiullah, Urwah Tanveer, Shahroz Alam, Ahmed Faraz Zafar, Sohail Safdar","doi":"10.4103/ajts.ajts_120_21","DOIUrl":"10.4103/ajts.ajts_120_21","url":null,"abstract":"<p><strong>Objective: </strong>The objective of the study is to assess the satisfaction level of doctors regarding their competence in the blood transfusion process and their reflection on training at the undergraduate level.</p><p><strong>Background: </strong>Transfusion errors due to suboptimal knowledge and lack of training can lead to grave outcomes. Therefore, to optimize patient care, a thorough understanding of transfusion medicine basics is highly imperative for all medical graduates.</p><p><strong>Methodology: </strong>This survey was conducted online through Google forms with a questionnaire consisting of 15 questions. 8 medical colleges (4 government and 4 private) were selected by random cluster sampling technique. Data were analyzed with SPSS version 23.</p><p><strong>Results: </strong>Of 502 participants, 53.8% were females and 69.9% were graduates of public medical colleges. About 84.6% did not receive any formal training on transfusion during graduation. Almost 82% felt that the current curriculum is not designed to meet their practical needs of blood transfusion and 52% agreed that knowledge of transfusion medicine is required for undergraduates. The survey also revealed that 70.5% of participants believed that whole blood is required for most patients and 49.8% did not feel confident to manage transfusion-related complications by themselves.</p><p><strong>Conclusion: </strong>Our survey showed that our undergraduate curriculum is not aligned with the practical transfusion needs of a young doctor. As transfusions are being carried out by these young doctors, this needs to be addressed by revising the current curriculum and incorporating teaching and hands-on training to our medical graduates.</p>","PeriodicalId":42296,"journal":{"name":"Asian Journal of Transfusion Science","volume":"18 2","pages":"230-236"},"PeriodicalIF":0.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11734779/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Smart approaches for encouraging the blood donation. 鼓励献血的聪明方法。
IF 0.6 Q4 HEMATOLOGY Pub Date : 2024-07-01 Epub Date: 2022-09-28 DOI: 10.4103/ajts.ajts_30_22
Rakesh Sharma, Debadri Banerjee, Anupama Singh, Vikas Anand Saharan

Blood is a life saver in many emergencies like accidents or for the patients suffering from deadly diseases such as cancer and thalassemia. Conventionally, blood collection is done in five steps, i.e., recruitment, screening, physical examination, collection, and postdonation care. The huge demand of blood requires the implementation of smart approaches in the field of blood donation, which allows specific, measurable, achievable, and timely outcomes. This paper throws light on various smart approaches to motivate and attract people for blood donation. Gamification, social media, short message service, mobile applications, and other web-based applications are some of these approaches reviewed in this article. A number of platforms are also highlighted where one can seek potential donors or blood banks easily during urgency, avoiding the complex steps followed in traditional blood donation systems.

在许多紧急情况下,如事故或患有致命疾病(如癌症和地中海贫血)的患者,血液是生命的拯救者。传统上,采血分为五个步骤,即招募、筛选、体检、采集和献血后护理。巨大的血液需求要求在献血领域实施智能方法,从而实现具体、可衡量、可实现和及时的结果。本文阐述了激励和吸引人们献血的各种聪明方法。游戏化、社交媒体、短消息服务、移动应用程序和其他基于web的应用程序是本文中讨论的一些方法。还强调了一些平台,在紧急情况下,人们可以轻松地寻找潜在的献血者或血库,避免了传统献血系统所遵循的复杂步骤。
{"title":"Smart approaches for encouraging the blood donation.","authors":"Rakesh Sharma, Debadri Banerjee, Anupama Singh, Vikas Anand Saharan","doi":"10.4103/ajts.ajts_30_22","DOIUrl":"10.4103/ajts.ajts_30_22","url":null,"abstract":"<p><p>Blood is a life saver in many emergencies like accidents or for the patients suffering from deadly diseases such as cancer and thalassemia. Conventionally, blood collection is done in five steps, i.e., recruitment, screening, physical examination, collection, and postdonation care. The huge demand of blood requires the implementation of smart approaches in the field of blood donation, which allows specific, measurable, achievable, and timely outcomes. This paper throws light on various smart approaches to motivate and attract people for blood donation. Gamification, social media, short message service, mobile applications, and other web-based applications are some of these approaches reviewed in this article. A number of platforms are also highlighted where one can seek potential donors or blood banks easily during urgency, avoiding the complex steps followed in traditional blood donation systems.</p>","PeriodicalId":42296,"journal":{"name":"Asian Journal of Transfusion Science","volume":"19 1","pages":"303-315"},"PeriodicalIF":0.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11734795/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79389497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of ABO, Rh (D, C, c, E, and e), and Kell (K) antigens in blood donors: A single-center study from South India. 献血者中ABO、Rh (D、C、C、E和E)和Kell (K)抗原的患病率:一项来自南印度的单中心研究
IF 0.6 Q4 HEMATOLOGY Pub Date : 2024-07-01 Epub Date: 2022-09-28 DOI: 10.4103/ajts.ajts_159_21
Banerjee Soumee, A M Shanthala Devi, Subramanian Sitalakshmi

Background: Although ABO and RhD are the clinically significant blood group antigens that are routinely tested for, other blood group antigens may become important in multiply transfused patients due to risk of alloimmunization. Knowledge of antigen prevalence in a population is important in the context of alloimmunization and antigen matching. This study aims to do the same in a population of voluntary blood donors of a center in South India.

Aims and objectives: To study the ABO, Rh (D, C, c, E, and e), and Kell (K) antigen and Rh phenotype prevalence in whole blood donors donating at the blood bank of a tertiary care hospital in South India.

Materials and methods: One thousand and two hundred eligible whole blood donors were chosen by random sampling between November 2017 and April 2019. After administration of informed consent and routine testing for ABO grouping, RhD typing, and indirect antiglobulin test, Rh and Kell typing was done on appropriate gelcards and the data were analyzed to arrive at phenotypes.

Results: 97.6% of the donors were male and 2.4% were female. They were divided into 7 different categories based on the regions of origin: Kerala, Andhra Pradesh, Tamil Nadu, Karnataka, West Bengal, North India, and others with the largest number of donors hailing from Karnataka (38.5%). The ABO distribution, in descending order, was as follows: O (38%), B (34.5%), A (20.6%), and AB (6.8%). The prevalence of the Rh antigens was as follows: D: 93.4%, C: 87.9%, c: 55.6%, E: 19.3%, and e: 98.8%. K was present in 1.4% of the population. Since genotyping has not been done, the most common "presumed" Rh phenotype among RhD-positive donors was R1R1 (46.4% of total donors and 49.5% of RhD-positive donors). The most common phenotype among RhD-negative donors was rr (5.9% of total donors and 92.2% of RhD-negative donors). The order of prevalence of the ABO, Rh, and K antigens and the Rh phenotypes remained the same irrespective of gender, ABO group, and region of origin.

Conclusion: This population-based study analyzes a donor population as a whole and separately as per regions of origin and shows that antigen prevalence and thereby risk of alloimmunization does not vary markedly among the different population subsections. Hence, even where extended phenotyping and antigen matching cannot be done, risk of alloimmunization may be low. Limiting antigen matching to specific patient subsets like in multiply transfused patients with uncommon phenotypes may, therefore, be an efficient and cost-effective approach.

背景:虽然ABO和RhD是常规检测的临床重要血型抗原,但由于同种异体免疫的风险,其他血型抗原可能在多次输血患者中变得重要。在同种异体免疫和抗原匹配的背景下,人群中抗原流行的知识是重要的。这项研究的目的是在印度南部一个中心的自愿献血者群体中做同样的事情。目的和目的:研究在印度南部某三级医院血库献血的全血献血者的ABO、Rh (D、C、C、E和E)和Kell (K)抗原和Rh表型的流行情况。材料与方法:2017年11月至2019年4月,随机抽取1200名符合条件的全血献血者。在获得知情同意并进行ABO分组、RhD分型和间接抗球蛋白测试的常规检测后,在适当的凝胶卡上进行Rh和Kell分型,并分析数据以获得表型。结果:献血者中男性占97.6%,女性占2.4%。他们根据原籍地区分为7个不同的类别:喀拉拉邦、安得拉邦、泰米尔纳德邦、卡纳塔克邦、西孟加拉邦、北印度,以及来自卡纳塔克邦的捐助者最多的其他地区(38.5%)。ABO血型分布由大到小依次为O型(38%)、B型(34.5%)、A型(20.6%)、AB型(6.8%)。Rh抗原的阳性率分别为:D: 93.4%, C: 87.9%, C: 55.6%, E: 19.3%, E: 98.8%。K在1.4%的人群中存在。由于没有进行基因分型,在Rh阳性供者中最常见的“假定”Rh表型是R1R1(占总供者的46.4%和Rh阳性供者的49.5%)。rh阴性供者中最常见的表型是rr(占总供者的5.9%,占rh阴性供者的92.2%)。ABO、Rh和K抗原和Rh表型的流行顺序与性别、ABO组和原产地区无关。结论:这项以人群为基础的研究分析了整个供体人群,并根据来源地区分别进行了分析,结果表明抗原流行率和异体免疫风险在不同人群亚群之间没有显著差异。因此,即使不能进行扩展表型和抗原匹配,同种异体免疫的风险也可能很低。因此,限制抗原与特定患者亚群的匹配,例如在多次输血的不常见表型患者中,可能是一种有效且具有成本效益的方法。
{"title":"Prevalence of ABO, Rh (D, C, c, E, and e), and Kell (K) antigens in blood donors: A single-center study from South India.","authors":"Banerjee Soumee, A M Shanthala Devi, Subramanian Sitalakshmi","doi":"10.4103/ajts.ajts_159_21","DOIUrl":"10.4103/ajts.ajts_159_21","url":null,"abstract":"<p><strong>Background: </strong>Although ABO and RhD are the clinically significant blood group antigens that are routinely tested for, other blood group antigens may become important in multiply transfused patients due to risk of alloimmunization. Knowledge of antigen prevalence in a population is important in the context of alloimmunization and antigen matching. This study aims to do the same in a population of voluntary blood donors of a center in South India.</p><p><strong>Aims and objectives: </strong>To study the ABO, Rh (D, C, c, E, and e), and Kell (K) antigen and Rh phenotype prevalence in whole blood donors donating at the blood bank of a tertiary care hospital in South India.</p><p><strong>Materials and methods: </strong>One thousand and two hundred eligible whole blood donors were chosen by random sampling between November 2017 and April 2019. After administration of informed consent and routine testing for ABO grouping, RhD typing, and indirect antiglobulin test, Rh and Kell typing was done on appropriate gelcards and the data were analyzed to arrive at phenotypes.</p><p><strong>Results: </strong>97.6% of the donors were male and 2.4% were female. They were divided into 7 different categories based on the regions of origin: Kerala, Andhra Pradesh, Tamil Nadu, Karnataka, West Bengal, North India, and others with the largest number of donors hailing from Karnataka (38.5%). The ABO distribution, in descending order, was as follows: O (38%), B (34.5%), A (20.6%), and AB (6.8%). The prevalence of the Rh antigens was as follows: D: 93.4%, C: 87.9%, c: 55.6%, E: 19.3%, and e: 98.8%. K was present in 1.4% of the population. Since genotyping has not been done, the most common \"presumed\" Rh phenotype among RhD-positive donors was R<sub>1</sub>R<sub>1</sub> (46.4% of total donors and 49.5% of RhD-positive donors). The most common phenotype among RhD-negative donors was rr (5.9% of total donors and 92.2% of RhD-negative donors). The order of prevalence of the ABO, Rh, and K antigens and the Rh phenotypes remained the same irrespective of gender, ABO group, and region of origin.</p><p><strong>Conclusion: </strong>This population-based study analyzes a donor population as a whole and separately as per regions of origin and shows that antigen prevalence and thereby risk of alloimmunization does not vary markedly among the different population subsections. Hence, even where extended phenotyping and antigen matching cannot be done, risk of alloimmunization may be low. Limiting antigen matching to specific patient subsets like in multiply transfused patients with uncommon phenotypes may, therefore, be an efficient and cost-effective approach.</p>","PeriodicalId":42296,"journal":{"name":"Asian Journal of Transfusion Science","volume":"12 1","pages":"219-224"},"PeriodicalIF":0.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11734788/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80667887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare case of late developing anti-E antibody in a pregnant female leading to severe hemolytic disease of the newborn: A missed follow-up in COVID-19 epoch. 1例罕见的晚期妊娠女性抗e抗体导致新生儿严重溶血性疾病:COVID-19期遗漏随访
IF 0.6 Q4 HEMATOLOGY Pub Date : 2024-07-01 Epub Date: 2023-11-07 DOI: 10.4103/ajts.ajts_52_23
Suhasini Sil, Daljit Kaur, Poonam Singh, Dixa Kumari, Ashish Jain, Gita Negi

With the use of Anti-D prophylaxis for rhesus D-negative pregnant women, other Rh and non-Rh allo-antibodies have become relatively more important. The index case reports severe hemolytic disease of the newborn due to anti-E antibody in a full-term baby boy born to a COVID-19-positive mother. The antibody screening of the mother performed during Booking of pregnancy at 9th week of gestation was negative. Subsequently the mother was lost to follow-up till delivery due to COVID pandemicity. At birth, the baby was icteric but non-hydropic, his direct antiglobulin test (DAT) was strong positive (4+ by column agglutination technology) and required top-up transfusion and phototherapy at Neonatal Intensive Care Unit. Elution of DAT-positive red cells rendered anti-E which could have formed as "late developing" red cell allo-anti-E in the pregnancy. A repeat antibody screening around 28th week gestation is of prime importance to detect any underlying allo-antibody in a multigravida and thus enabling close monitoring of fetus and initiation of early management as desired.

随着对恒河猴d阴性孕妇使用抗d预防,其他Rh和非Rh同种异体抗体变得相对更重要。该指示病例报告了一名covid -19阳性母亲所生的足月男婴因抗e抗体导致的新生儿严重溶血性疾病。母亲在妊娠第9周预约妊娠期间进行的抗体筛查为阴性。随后,由于新冠肺炎大流行,母亲未能随访至分娩。出生时,婴儿黄疸但无积水,他的直接抗球蛋白试验(DAT)呈强阳性(柱凝集技术4+),需要在新生儿重症监护病房补充输血和光疗。洗脱的dat阳性红细胞可产生抗e,这可能是在妊娠期形成的“晚期”红细胞同种异体抗e。妊娠28周前后的重复抗体筛查对于发现多胎孕妇潜在的同种异体抗体至关重要,从而能够密切监测胎儿并根据需要开始早期治疗。
{"title":"A rare case of late developing anti-E antibody in a pregnant female leading to severe hemolytic disease of the newborn: A missed follow-up in COVID-19 epoch.","authors":"Suhasini Sil, Daljit Kaur, Poonam Singh, Dixa Kumari, Ashish Jain, Gita Negi","doi":"10.4103/ajts.ajts_52_23","DOIUrl":"10.4103/ajts.ajts_52_23","url":null,"abstract":"<p><p>With the use of Anti-D prophylaxis for rhesus D-negative pregnant women, other Rh and non-Rh allo-antibodies have become relatively more important. The index case reports severe hemolytic disease of the newborn due to anti-E antibody in a full-term baby boy born to a COVID-19-positive mother. The antibody screening of the mother performed during Booking of pregnancy at 9<sup>th</sup> week of gestation was negative. Subsequently the mother was lost to follow-up till delivery due to COVID pandemicity. At birth, the baby was icteric but non-hydropic, his direct antiglobulin test (DAT) was strong positive (4+ by column agglutination technology) and required top-up transfusion and phototherapy at Neonatal Intensive Care Unit. Elution of DAT-positive red cells rendered anti-E which could have formed as \"late developing\" red cell allo-anti-E in the pregnancy. A repeat antibody screening around 28<sup>th</sup> week gestation is of prime importance to detect any underlying allo-antibody in a multigravida and thus enabling close monitoring of fetus and initiation of early management as desired.</p>","PeriodicalId":42296,"journal":{"name":"Asian Journal of Transfusion Science","volume":"18 2","pages":"336-340"},"PeriodicalIF":0.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11734769/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143012970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment: Passenger lymphocyte syndrome as a rare cause of hemolysis in a patient after small intestine transplantation - A case report and review of the literature. 评论:乘客淋巴细胞综合征作为小肠移植后患者溶血的罕见原因- 1例报告和文献复习。
IF 0.6 Q4 HEMATOLOGY Pub Date : 2024-07-01 Epub Date: 2023-05-11 DOI: 10.4103/ajts.ajts_147_22
Will Thomas
{"title":"Comment: Passenger lymphocyte syndrome as a rare cause of hemolysis in a patient after small intestine transplantation - A case report and review of the literature.","authors":"Will Thomas","doi":"10.4103/ajts.ajts_147_22","DOIUrl":"https://doi.org/10.4103/ajts.ajts_147_22","url":null,"abstract":"","PeriodicalId":42296,"journal":{"name":"Asian Journal of Transfusion Science","volume":"18 2","pages":"373-374"},"PeriodicalIF":0.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11734807/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of blood donation on wheels in the blood collection chain operational logistics during the first wave of coronavirus disease 2019 pandemic. 2019冠状病毒病第一波大流行期间,车轮献血在采血链运营物流中的作用。
IF 0.6 Q4 HEMATOLOGY Pub Date : 2024-07-01 Epub Date: 2024-08-22 DOI: 10.4103/ajts.ajts_64_24
Suchet Sachdev, Nippun Prinja, Sangeeta Kumari, Lakhvinder Singh, Divjot Singh Lamba, Hari Krishan Dhawan, Ratti Ram Sharma

Background and objectives: The blood collection agencies (BCAs) employ two major logistical modes of conduct for outdoor blood collection. First, the collection agency walks to the donor's preferred location for routine blood donation drives. Second, the drive is conducted using a heavy-duty vehicle having all the facilities for blood donation in it - Blood Donation on Wheels - hereinafter referred to as mobile blood drive (MBD). The study aimed to review the role of MBDs during the coronavirus disease 2019 (COVID-19) pandemic.

Materials and methods: This was a retrospective analysis of data concerning the blood collection at the outdoor blood donation drives such as the number of drives, blood donations in voluntary (total outdoor), routine blood drive (RBD), and MBDs during the COVID-19 pandemic with respect to referent data.

Results: There was a trend in the increase in MBDs (43.3% in 2020 vs. 35.6% in 2019), with odds of 1.38 (confidence interval [CI]: 0.99-1.9), P = 0.05, during the pandemic. There was a statistically significant increase in contribution in terms of blood donations from MBDs (25.8% in 2020 vs. 19.5% in 2019), with odds of 1.43 (CI: 1.4-1.5), P < 0.05, during the pandemic. There was a statistically significant reduction in the rates of vasovagal reactions in blood donors donating blood at voluntary blood drives, RBD, and MBDs during the pandemic, in comparison with the referent data.

Conclusion: The blood donation on wheels compliments the public outreach efforts of the BCAs, both in terms of the organization of the outdoor blood donation drives and the blood donations obtained thereof.

背景和目的:采血机构(bca)采用两种主要的后勤模式进行户外采血。首先,收集机构步行到献血者首选的地点进行常规献血活动。第二,献血活动使用的是一辆配备了所有献血设施的重型车辆——车轮献血,以下简称“移动献血”。该研究旨在回顾MBDs在2019冠状病毒病(COVID-19)大流行期间的作用。材料与方法:回顾性分析2019冠状病毒病大流行期间各户外献血活动的采血数据,如献血次数、自愿献血(室外总献血)、常规献血(RBD)、MBDs等。结果:疫情期间MBDs呈上升趋势(2020年为43.3%,2019年为35.6%),比值为1.38(可信区间[CI]: 0.99 ~ 1.9), P = 0.05。在大流行期间,mbd的献血量贡献有统计学意义的增加(2020年为25.8%,2019年为19.5%),比值为1.43 (CI: 1.4 ~ 1.5), P < 0.05。与参考数据相比,在大流行期间自愿献血、RBD和MBDs献血的献血者血管迷走神经反应的发生率在统计学上显著降低。结论:车轮献血无论在组织户外献血活动方面还是在获得的献血量方面,都对bca的公共宣传工作给予了肯定。
{"title":"The role of blood donation on wheels in the blood collection chain operational logistics during the first wave of coronavirus disease 2019 pandemic.","authors":"Suchet Sachdev, Nippun Prinja, Sangeeta Kumari, Lakhvinder Singh, Divjot Singh Lamba, Hari Krishan Dhawan, Ratti Ram Sharma","doi":"10.4103/ajts.ajts_64_24","DOIUrl":"https://doi.org/10.4103/ajts.ajts_64_24","url":null,"abstract":"<p><strong>Background and objectives: </strong>The blood collection agencies (BCAs) employ two major logistical modes of conduct for outdoor blood collection. First, the collection agency walks to the donor's preferred location for routine blood donation drives. Second, the drive is conducted using a heavy-duty vehicle having all the facilities for blood donation in it - Blood Donation on Wheels - hereinafter referred to as mobile blood drive (MBD). The study aimed to review the role of MBDs during the coronavirus disease 2019 (COVID-19) pandemic.</p><p><strong>Materials and methods: </strong>This was a retrospective analysis of data concerning the blood collection at the outdoor blood donation drives such as the number of drives, blood donations in voluntary (total outdoor), routine blood drive (RBD), and MBDs during the COVID-19 pandemic with respect to referent data.</p><p><strong>Results: </strong>There was a trend in the increase in MBDs (43.3% in 2020 vs. 35.6% in 2019), with odds of 1.38 (confidence interval [CI]: 0.99-1.9), <i>P</i> = 0.05, during the pandemic. There was a statistically significant increase in contribution in terms of blood donations from MBDs (25.8% in 2020 vs. 19.5% in 2019), with odds of 1.43 (CI: 1.4-1.5), <i>P</i> < 0.05, during the pandemic. There was a statistically significant reduction in the rates of vasovagal reactions in blood donors donating blood at voluntary blood drives, RBD, and MBDs during the pandemic, in comparison with the referent data.</p><p><strong>Conclusion: </strong>The blood donation on wheels compliments the public outreach efforts of the BCAs, both in terms of the organization of the outdoor blood donation drives and the blood donations obtained thereof.</p>","PeriodicalId":42296,"journal":{"name":"Asian Journal of Transfusion Science","volume":"18 2","pages":"159-167"},"PeriodicalIF":0.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11734785/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Asian Journal of Transfusion Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1